Idelalisib Combo Rings Bells in Relapsed CLL
Patients with relapsed chronic lymphocytic leukemia, who were less able to undergo chemotherapy, had improved OS with a combination of idelalisib and rituximab, in a study reported by Dr Bruce Cheson.
Source: Medscape Oncology - Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
More News: Cancer & Oncology | Chemotherapy | Chronic Leukemia | Chronic Lymphocytic Leukemia | Leukemia | Rituxan | Study